Clinical Trial Results
Clinical Trial
Results
Research Sponsor: AstraZeneca AB
Drugs Studied: AZD7594
National Clinical Trial #: NCT02928354
Eudra CT #: 2016-003397-41
Protocol #: D3741C00006
Study Date: November 2016 to March 2017
Short Study Title: A study in healthy male volunteers to learn how different
inhaler treatments of AZD7594 act in the body
Thank you!
As a clinical study participant, you belong to a large community of participants around
the world. You help researchers answer important health questions and discover new
medical treatments.
Thank you for taking part in this clinical study for the drug AZD7594. This drug is being
developed to treat chronic obstructive pulmonary disease, also known as COPD, and
asthma. You and all of the other participants helped researchers learn how different
inhaled forms of AZD7594 act in the body and if AZD7594 causes any medical problems.
AstraZeneca AB, the sponsor of this study, thanks you for your help and thinks it
is important for you to know the results of your study. An independent non-profit
organization called CISCRP prepared this summary of the study results for you with
the help of a medical writing organization.
We hope it helps you understand and feel proud of your important role in medical
research. If you have questions about the results, please speak with the study doctors
or staff at your study site.
11